Thomas Joseph Povsic, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail DUMC Box 103208, Durham, NC 27710
Phone (919) 684-1284
Email address povsi001@mc.duke.edu

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1998 - 2004
  • Medical Resident, Medicine, Duke University, 1995 - 1998
  • M.D., Harvard University , 1995

Publications

Povsic, Thomas J., Ricardo Sanz-Ruiz, Andreu M. Climent, Roberto Bolli, Doris A. Taylor, Bernard J. Gersh, Philippe Menasché, et al. “Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies.” Esc Heart Fail 8, no. 3 (June 2021): 2306–9. https://doi.org/10.1002/ehf2.13256.

PMID
33652498
Full Text

Januzzi, James L., John M. Canty, Saumya Das, Christopher R. DeFilippi, Gary A. Gintant, David E. Gutstein, Allan Jaffe, et al. “Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week.” J Am Coll Cardiol 77, no. 15 (April 20, 2021): 1922–33. https://doi.org/10.1016/j.jacc.2021.02.040.

PMID
33858628
Full Text

Bartunek, Jozef, Andre Terzic, Beth A. Davison, Atta Behfar, Ricardo Sanz-Ruiz, Wojciech Wojakowski, Warren Sherman, et al. “Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes.” Esc Heart Fail, October 23, 2020. https://doi.org/10.1002/ehf2.13031.

PMID
33094909
Full Text

Johnson, Grace L., Timothy D. Henry, Thomas J. Povsic, Douglas W. Losordo, Ross F. Garberich, Larissa I. Stanberry, Craig E. Strauss, and Jay H. Traverse. “CD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina.” In Stem Cells Transl Med, 9:1147–52, 2020. https://doi.org/10.1002/sctm.20-0046.

PMID
32531108
Full Text

Makkar, Raj R., Dean J. Kereiakes, Frank Aguirre, Glenn Kowalchuk, Tarun Chakravarty, Konstantinos Malliaras, Gary S. Francis, et al. “Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.” Eur Heart J 41, no. 36 (September 21, 2020): 3451–58. https://doi.org/10.1093/eurheartj/ehaa541.

PMID
32749459
Full Text

Lewinski, Dirk von, Joseph B. Selvanayagam, Richard A. Schatz, Bernd Jilma, Jacek Kubica, Thomas J. Povsic, Darrell Nix, Stephan Henauer, Markus Wallner, and Markus REC-DUT-002 study group. “"Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction": study protocol for a randomized controlled trial.” Trials 21, no. 1 (August 26, 2020): 744. https://doi.org/10.1186/s13063-020-04652-0.

PMID
32843081
Full Text

Shavadia, Jay S., Christopher B. Granger, Wendimagegn Alemayehu, Cynthia M. Westerhout, Thomas J. Povsic, Sean Van Diepen, Christopher Defilippi, and Paul W. Armstrong. “Novel Biomarkers, ST-Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention.” J Am Heart Assoc 9, no. 13 (July 7, 2020): e016033. https://doi.org/10.1161/JAHA.120.016033.

PMID
32552321
Full Text

Marquis-Gravel, Guillaume, Zhen Huang, Steven L. Zelenkofske, A Michael Lincoff, Roxana Mehran, P Gabriel Steg, Christoph Bode, John H. Alexander, and Thomas J. Povsic. “Interplay between PCI access site, anticoagulant agent, and bleeding: Insights from the REGULATE-PCI randomized trial.” Am Heart J 223 (May 2020): 84–86. https://doi.org/10.1016/j.ahj.2020.02.013.

PMID
32199152
Full Text

Pages